Topics and Expertise: pharmacogenomics

Kroetz brings expertise in both science and pharmacy education to her new role as department chair.

Every day, on average, ten new genetic tests become commercially available to help doctors and patients make more informed decisions about health care.

Kathy Giacomini, PhD, has been named the 2018 Volwiler Research Achievement Award recipient by the American Association of Colleges of Pharmacy.

Kathy Giacomini, PhD, a leader in the field of pharmacogenomics, has been named the 2017 recipient of the North American Scientific Achievement Award, presented by the International Society for the Study of Xenobiotics (ISSX). ISSX is an international association of scientists that promotes the...

Kathy Giacomini, PhD, has been named the 2017 recipient of the Henry W. Elliott Distinguished Service Award from the American Society for Clinical Pharmacology and Therapeutics (ASCPT).

Founded in 1900, ASCPT comprises more than 2,200 members whose primary interest is to advance the science and...

Studies of pharmacogenetics testing of pharmacy students as a teaching tool, an improved system to resolve medication issues after patients go home from the hospital, and the prophylactic use of an antiseizure drug for brain surgery patients took top honors at the Department of Clinical Pharmacy...

For the 36th consecutive year, the UCSF School of Pharmacy has received more funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.

In people with type 2 diabetes, the body is less able to use the hormone insulin to regulate blood sugar. The disease affects 350 million patients globally—including 29 million in the United States, where it is the leading cause of blindness, kidney failure, and non-accident-related amputations.

Taxanes are a class of drugs widely used to treat a variety of cancers, including breast, ovarian, lung, gastric, and head and neck. But dosages are often limited by toxic side effects—most commonly damage to the body’s peripheral nerves, causing numbness, pain, and/or hyper-sensitivity—that can...

Allopurinol, the first-choice medication for treating gout—an excruciatingly painful condition that is the most common form of inflammatory arthritis, afflicts more than eight million Americans, and is on the rise worldwide—is not fully effective in more than half of patients.